Liquid chromatography clean-up method to improve identification of anabolic agents in human urine by gas chromatography-mass spectrometry

Analytica Chimica Acta

Volumn 522, Issue 1, 2004, Pages 79-88

  Marcos, J ^a,b   De La Torre, X ^a,b   Gonzalez, J C ^a,b   Segura, J ^a,b   Pascual, J A ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Anabolic steroids; Doping; GC MS; Ion trap; LC

Indexed keywords

HUMAN URINE; STEROIDS;

ENZYMES; EVAPORATION; HYDROLYSIS; MASS SPECTROMETRY; METABOLITES;

LIQUID CHROMATOGRAPHY;

17ALPHA METHYL 5BETA ANDROSTANE 3ALPHA,17BETA DIOL; 17ALPHA METHYLANDROSTANE 3ALPHA,17BETA DIOL; 17BETA METHYL 5BETA ANDROST 1 ENE 3ALPHA,17ALPHA DIOL; 19 NORANDROSTERONE; 19 NORETIOCHOLANOLONE; 3' HYDROXYSTANOZOLOL; 4BETA HYDROXYSTANOZOLOL; ANABOLIC AGENT; ANDROGEN; CLENBUTEROL; STEROID; TRIMETHYLSILYL DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALCULATION; CONTROLLED STUDY; DERIVATIZATION; DOPING; DRUG ABUSE; DRUG URINE LEVEL; ELUTION; EVAPORATION; GAS CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OBSERVER VARIATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION;

EID: 4444237156     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2004.03.021     Document Type: Article

References (37)

1. Prohibited Classes of Substances and Prohibited Methods 2003, Substitutes Appendix A in Olympic Movement Anti-Doping Code, IOC, Lausanne, 1999.
2. M. Donike, H. Geyer, A. Gotzmann, M. Kraft, F. Mandel, E. Nolteernsting, G. Opfermann, G. Sigmund, W. Schanzer, J. Zimmermann, in: P. Belloti, G. Benzi, A. Ljungqvist (Eds.), Dope Analysis, Official Proceedings of the First International Athletic Foundation World Symposium on Doping in Sport, IAF, Florence, 1988, p. 53.
3. Segura J., Pascual J.A., Ventura R., Ustaran J.I., Cuevas A., Gonzalez R. Clin. Chem. 39:1993;836
4. Ayotte C., Goudreault D., Charlebois A. J. Chromatogr. B. 687:1996;3
5. Laboratory analysis procedures, in: Appendix D, Olympic Movement Anti-doping Code, IOC, Lausanne, 1999.
6. International Standard for Laboratories, Version 3.0, WADA, Montreal, 2003.
7. International Olympic Committee, Analytical criteria for reporting low concentrations of anabolic steroids, Internal Communication, IOC, Lausanne, 1998.
8. Van Ginkel L.A., Jansen E.H.J.M., Stephany R.W., Zoontjes P.W., Schwillens P.L.W.J., Van Rossum H.J., Visser T. J. Chromatogr. 624:1992;389
9. Machnik M., Geyer H., Horning S., Breidbach A., Delahaut P., Schanzer W. J. Chromatogr. B. 723:1999;147
10. Rashid B.A., Kwasowski P., Stevenson D. J. Pharm. Biomed. Anal. 21:1999;635
11. Schänzer W., Delahaut P., Geyer H., Machnik M., Horning S. J. Chromatogr. B. 687:1996;93
12. Desroches M.C., Mathurin J.C., Richard Y., Delahaut P., de Ceaurriz J. Rapid Commun. Mass Spectrom. 16:2002;370
13. Le Bizec B., Monteau F., Gaudin I., Andre F. J. Chromatogr. B. 723:1999;157
14. Navajas R., Imaz C., Carreras D., Garcia M., Perez M., Rodriguez C., Rodríguez A.F., Cortes R. J. Chromatogr. B. 673:1995;159
15. Kuronen P., Volin P., Laitalainen T. J. Chromatogr. B. 718:1998;211
16. Gonzalez Gigosos P., Fernandez Fernandez T., Cadahia Mariz O., Fente Sampayo C.A., Franco Abuin C., Cepeda Saez A. J. Chromatogr. B. 677:1996;167
17. Gleixner A., Sauerwein H., Meyer H.H. Clin. Chem. 42:1996;1869
18. Brambilla G., Fiori M., Rizzo B., Crescenzi V., Masci G. J. Chromatogr. B. 759:2001;27
19. A. Gotzmann, H. Geyer, W. Schänzer, in: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.), Recent Advances in Doping Analysis, Sport und Buch StrauB, Edition Sport, Cologne, 1996, p. 239.
20. Munoz-Guerra J., Carreras D., Soriano C., Rodríguez C., Rodríguez A.F. J. Chromatogr. B. 704:1997;105
21. Marcos J., Pascual J.A., de la Torre X., Segura J. J. Mass Sepctrom. 37:2002;1059
22. Schänzer W. Clin. Chem. 42:1996;1001
23. Schänzer W., Donike M. Anal. Chim. Acta. 275:1993;23
24. International Conference on Harmonization (ICH), Topic Q2B, Validation of Analytical Procedures: Methodology, ICH, Geneva, 1996.
25. S.B. Karch (Ed.), Drug Abuse Handbook, CRC Press, New York, p. 671.
26. Minimum required performance limits for detection of prohibited substances, WADA Technical Document TD2004MRPL, World Anti-Doping Agency, Montreal, 2004.
27. Shackleton C.H.L., Phillips A., Chang T., Li Y. Steroids. 62:1997;379
28. de la Torre X., Gonzalez J.C., Pichini S., Pascual J.A., Segura J. Adv. Mass Spectrom. 15:2001;601
29. Aguilera R., Becchi M., Grenot C., Casabianca H., Hatton C.K. J. Chromatogr. B. 687:1996;43
30. Edlund P.O., Bowers L.D., Henion J.D. J. Chromatogr. 487:1989;341
31. Barron D., Pascual J.A., Segura J., Barbosa J. Chromatographia. 41:1995;573
32. Mück W.M., Henian J.D. Biomed. Environ. Mass Spectrom. 19:1990;37
33. Borts D.J., Bowers L.D. J. Mass Spectrom. 35:2000;50
34. Kuuranne T., Kotiaho T., Pedersen-Bjergaard S., Rasmussen K.E., Leinonen A., Westwood S., Kostiainen R. J. Mass Spectrom. 38:2003;16
35. van Hout M.W.J., Niederlander H.A.G., de Zeeuw R.A., de Jong G.J. Rapid Commun. Mass Spectrom. 17:2003;245
36. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., Olah T. J. Am. Soc. Mass Spectrom. 11:2000;942
37. Leinonen A., Kuuranne T., Kostiainen R. J. Mass Spectrom. 37:2002;693